Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1986 1
1987 1
1988 2
1990 2
1991 1
1992 1
1995 1
1996 4
1997 2
1999 5
2000 10
2001 14
2002 4
2003 11
2004 4
2005 6
2006 6
2007 9
2008 14
2009 12
2010 15
2011 9
2012 9
2013 6
2014 16
2015 24
2016 21
2017 24
2018 26
2019 21
2020 27
2021 30
2022 29
2023 50
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

393 results

Results by year

Filters applied: . Clear all
Page 1
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.
Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, Chen J, Dayton BD, Ding H, Enschede SH, Fairbrother WJ, Huang DC, Hymowitz SG, Jin S, Khaw SL, Kovar PJ, Lam LT, Lee J, Maecker HL, Marsh KC, Mason KD, Mitten MJ, Nimmer PM, Oleksijew A, Park CH, Park CM, Phillips DC, Roberts AW, Sampath D, Seymour JF, Smith ML, Sullivan GM, Tahir SK, Tse C, Wendt MD, Xiao Y, Xue JC, Zhang H, Humerickhouse RA, Rosenberg SH, Elmore SW. Souers AJ, et al. Among authors: tahir sk. Nat Med. 2013 Feb;19(2):202-8. doi: 10.1038/nm.3048. Epub 2013 Jan 6. Nat Med. 2013. PMID: 23291630
ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.
Tse C, Shoemaker AR, Adickes J, Anderson MG, Chen J, Jin S, Johnson EF, Marsh KC, Mitten MJ, Nimmer P, Roberts L, Tahir SK, Xiao Y, Yang X, Zhang H, Fesik S, Rosenberg SH, Elmore SW. Tse C, et al. Among authors: tahir sk. Cancer Res. 2008 May 1;68(9):3421-8. doi: 10.1158/0008-5472.CAN-07-5836. Cancer Res. 2008. PMID: 18451170
Awareness during Cardiopulmonary Resuscitation.
Asghar A, Salim B, Tahir S, Islam F, Khan MF. Asghar A, et al. Among authors: tahir s. Indian J Crit Care Med. 2020 Feb;24(2):136-137. doi: 10.5005/jp-journals-10071-23345. Indian J Crit Care Med. 2020. PMID: 32205947 Free PMC article.
The need for dietary guidelines in Pakistan.
Iqbal R, Tahir S, Ghulamhussain N. Iqbal R, et al. Among authors: tahir s. J Pak Med Assoc. 2017 Aug;67(8):1258-1261. J Pak Med Assoc. 2017. PMID: 28839315 Review.
β-arrestin signalling and bias in hormone-responsive GPCRs.
Reiter E, Ayoub MA, Pellissier LP, Landomiel F, Musnier A, Tréfier A, Gandia J, De Pascali F, Tahir S, Yvinec R, Bruneau G, Poupon A, Crépieux P. Reiter E, et al. Among authors: tahir s. Mol Cell Endocrinol. 2017 Jul 5;449:28-41. doi: 10.1016/j.mce.2017.01.052. Epub 2017 Feb 4. Mol Cell Endocrinol. 2017. PMID: 28174117 Review.
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia.
Tahir SK, Calvo E, Carneiro BA, Yuda J, Shreenivas A, Jongen-Lavrencic M, Gort E, Ishizawa K, Morillo D, Biesdorf C, Smith M, Cheng D, Motwani M, Sharon D, Uziel T, Modi DA, Buchanan FG, Morgan-Lappe S, Medeiros BC, Phillips DC. Tahir SK, et al. Blood. 2023 Apr 27;141(17):2114-2126. doi: 10.1182/blood.2022017333. Blood. 2023. PMID: 36720090 Free PMC article.
Antimicrobial resistance: more than 70 years of war between humans and bacteria.
Nadeem SF, Gohar UF, Tahir SF, Mukhtar H, Pornpukdeewattana S, Nukthamna P, Moula Ali AM, Bavisetty SCB, Massa S. Nadeem SF, et al. Among authors: tahir sf. Crit Rev Microbiol. 2020 Sep;46(5):578-599. doi: 10.1080/1040841X.2020.1813687. Epub 2020 Sep 19. Crit Rev Microbiol. 2020. PMID: 32954887 Review.
393 results